Osvaldo D. Castelán-Martínez

Author

Universidad Nacional Autónoma de México ORCID

Also Known As

O. D. Castelán-Martínez, O.D. Castelán-Martínez, Osvaldo Castelán‑Martínez, Osvaldo D Castelán-Martínez, Osvaldo D. Castelan-Martinez, Osvaldo D. Castelán-Martínez, Osvaldo Daniel Castelán-Martínez, Osvaldo Daniel Castelán-Martínez, Osvaldo-Daniel Castelan-Martínez

Publications

284

Citations

H-Index

Concepts

All Affiliations

Universidad Nacional Autónoma de México Instituto Politécnico Nacional Hospital Infantil de México Federico Gómez Mexican Social Security Institute Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

About

Osvaldo D. Castelán-Martínez is an author at Universidad Nacional Autónoma de México specializing in medicine, pediatrics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	61
2	Public Health	2	2	37
3	Arts	1	1	24
4	Pathology	1	1	11
5	Population	1	1	26

Osvaldo D. Castelán-Martínez

Publications

141

Citations

H-Index

Page 1

	Year	Citations
Allele frequency distribution of CYP2C92 and CYP2C93 polymorphisms in six Mexican populations Osvaldo D. Castelán-Martínez, Carlos Hoyo‐Vadillo, Emmanuel Sandoval, Gene Allelic VariantGenetic DeterminantGenotype-phenotype AssociationHuman VariationMexican Populations	2013	26
Hearing loss in Mexican children treated with cisplatin Osvaldo D. Castelán-Martínez, Ricardo Jiménez‐Méndez, Felipe Rodríguez-Islas, International Journal of Pediatric Otorhinolaryngology Aural RehabilitationPediatric OtolaryngologyPediatric AudiologyAudiologyPediatrics	2014	24
Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors Clímaco Andres Jiménez-Triana, Osvaldo D. Castelán-Martínez, Rodolfo Rivas-Ruíz, Medicine	2015	24
Association of rs2000999 in the haptoglobin gene with total cholesterol, HDL-C, and LDL-C levels in Mexican type 2 diabetes patients Fernando Suárez‐Sánchez, Miguel Vázquez‐Moreno, Ema E. Herrera-Lopez, Medicine	2019	19
<i>CYP2C9*3</i> gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide Osvaldo D. Castelán-Martínez, Carlos Hoyo‐Vadillo, T. B. Bazán-Soto, Journal of Clinical Pharmacy and Therapeutics	2018	17
Risk Factors for Febrile Neutropenia in Children With Solid Tumors Treated With Cisplatin-based Chemotherapy Osvaldo D. Castelán-Martínez, Felipe Rodríguez-Islas, Jessica Liliana Vargas-Neri, Journal of Pediatric Hematology/Oncology PathologyPharmacotherapyMetronomic ChemotherapyFebrile NeutropeniaIndependent Risk Factors	2016	11
[Apa1 VDR polymorphism and osteoporosis risk in postmenopausal Mexican women]. Osvaldo D. Castelán-Martínez, Nalleli Vivanco-Muñoz, Edith Falcón-Ramírez, PubMed	2016	10
[Anthracycline-induced cardiotoxicity: report of fatal cases]. Jessica Liliana Vargas-Neri, Osvaldo D. Castelán-Martínez, María de Jesús Estrada-Loza, PubMed	2017	10

Page 1